Hypoglycemia and Risk of Cardiovascular Disease and All-Cause Mortality in Insulin-Treated People With Type 1 and Type 2 Diabetes: A Cohort Study

被引:264
|
作者
Khunti, Kamlesh [1 ,2 ]
Davies, Melanie [1 ,2 ]
Majeed, Azeem [3 ]
Thorsted, Brian Larsen [4 ]
Wolden, Michael Lyng [4 ]
Paul, Sanjoy K. [5 ]
机构
[1] Univ Leicester, Leicester Diabet Ctr, Leicester, Leics, England
[2] Univ Leicester, Leicester Clin Trials Unit, Leicester, Leics, England
[3] Univ London Imperial Coll Sci Technol & Med, Dept Publ Hlth & Primary Care, London, England
[4] Novo Nordisk AS, Bagsvaerd, Denmark
[5] QIMR Berghofer Med Res Inst, Clin Trials & Biostat Unit, Brisbane, Qld, Australia
关键词
GLYCEMIC CONTROL; GLUCOSE CONTROL; COMPLICATIONS; VETERANS; EVENTS;
D O I
10.2337/dc14-0920
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVEHypoglycemia has been associated with an increased risk of cardiovascular (CV) events and all-cause mortality. This study assessed whether, in a nationally representative population, there is an association between hypoglycemia, the risk of CV events, and all-cause mortality among insulin-treated people with type 1 diabetes or type 2 diabetes.RESEARCH DESIGN AND METHODSThis retrospective cohort study used data from the Clinical Practice Research Datalink database and included all insulin-treated patients (30 years of age) with a diagnosis of diabetes.RESULTSIn patients who experienced hypoglycemia, hazard ratios (HRs) for CV events in people with type 1 diabetes were 1.51 (95% CI 0.83, 2.75; P = ns) and 1.61 (1.17, 2.22), respectively, for those with and without a history of CV disease (CVD) before the index date. In people with type 2 diabetes, the HRs for patients with and without a history of CVD were 1.60 (1.21, 2.12) and 1.49 (1.23, 1.82), respectively. For all-cause mortality, HRs in people with type 1 diabetes were 1.98 (1.25, 3.17), and 2.03 (1.66, 2.47), respectively, for those with and without a history of CVD. Among people with type 2 diabetes, HRs were 1.74 (1.39, 2.18) and 2.48 (2.21, 2.79), respectively, for those with and without a history of CVD. The median time (interquartile range) from first hypoglycemia event to first CV event was 1.5 years (0.5, 3.5 years) and 1.5 years (0.5, 3.0 years), respectively, for people with type 1 and type 2 diabetes.CONCLUSIONSHypoglycemia is associated with an increased risk of CV events and all-cause mortality in insulin-treated patients with diabetes. The relationship between hypoglycemia and CV outcomes and mortality exists over a long period.
引用
收藏
页码:316 / 322
页数:7
相关论文
共 50 条
  • [1] Hypoglycemia and Risk of Cardiovascular Disease and All-Cause Mortality in Insulin-Treated People With Type 1 and Type 2 Diabetes: A Cohort Study. Diabetes Care 2015;38:316-322
    Gimenez, Marga
    Amor, Antonio J.
    Quiros, Carmen
    Conget, Ignacio
    DIABETES CARE, 2015, 38 (06) : E91 - E91
  • [2] Pioglitazone Exposure Reduced the Risk of All-Cause Mortality in Insulin-Treated Patients with Type 2 Diabetes Mellitus
    Yen, Fu-Shun
    Wang, Hsiang-Chi
    Pan, Chun-Wei
    Wei, James Cheng-Chung
    Hsu, Chih-Cheng
    Hwu, Chii-Min
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2020, 105 (03): : E401 - E409
  • [3] All-Cause and Cardiovascular Mortality Among Insulin-Naive People With Type 2 Diabetes Treated With Insulin Detemir or Glargine: A Cohort Study in the UK
    Husemoen, Lise Lotte Nystrup
    Morch, Lina S.
    Christensen, Per K.
    Hartvig, Niels V.
    Feher, Michael D.
    DIABETES THERAPY, 2021, 12 (05) : 1299 - 1311
  • [4] Severe Hypoglycemia and Cardiovascular or All-Cause Mortality in Patients with Type 2 Diabetes
    Cha, Seon-Ah
    Yun, Jae-Seung
    Lim, Tae-Seok
    Hwang, Seawon
    Yim, Eun-Jung
    Song, Ki-Ho
    Yoo, Ki-Dong
    Park, Yong-Moon
    Ahn, Yu-Bae
    Ko, Seung-Hyun
    DIABETES & METABOLISM JOURNAL, 2016, 40 (03) : 202 - 210
  • [5] All-Cause and Cardiovascular Mortality Among Insulin-Naïve People With Type 2 Diabetes Treated With Insulin Detemir or Glargine: A Cohort Study in the UK
    Lise Lotte Nystrup Husemoen
    Lina S. Mørch
    Per K. Christensen
    Niels V. Hartvig
    Michael D. Feher
    Diabetes Therapy, 2021, 12 : 1299 - 1311
  • [6] PREDICTING THE RISK OF NOCTURNAL HYPOGLYCEMIA AT BEDTIME FOR INSULIN-TREATED PEOPLE WITH TYPE 2 DIABETES
    Kronborg, T.
    Hejlesen, O.
    Vestergaard, P.
    Jensen, M. H.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 : A28 - A29
  • [7] Predictors of all-cause and cardiovascular disease mortality in type 2 diabetes: Diabetes Heart Study
    Laura M. Raffield
    Fang-Chi Hsu
    Amanda J. Cox
    J. Jeffrey Carr
    Barry I. Freedman
    Donald W. Bowden
    Diabetology & Metabolic Syndrome, 7
  • [8] ADIPONECTIN AND ALL-CAUSE MORTALITY IN A COHORT OF ELDERLY PEOPLE WITH TYPE 2 DIABETES
    Singer, Jessica Rohman
    Palmas, Walter
    Shea, Steven
    Luchsinger, Jose Alejandro
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2011, 26 : S5 - S5
  • [9] Predictors of all-cause and cardiovascular disease mortality in type 2 diabetes: Diabetes Heart Study
    Raffield, Laura M.
    Hsu, Fang-Chi
    Cox, Amanda J.
    Carr, J. Jeffrey
    Freedman, Barry I.
    Bowden, Donald W.
    DIABETOLOGY & METABOLIC SYNDROME, 2015, 7
  • [10] Associations of lipoprotein subclasses with risk of all-cause and cardiovascular disease mortality in individuals with type 2 diabetes: A prospective cohort study
    Li, Rui
    Chen, Jun-Xiang
    Lu, Qi
    Geng, Ting-Ting
    Xia, Peng-Fei
    Wang, Yi
    Chen, Liang-Kai
    Shan, Zhi-Lei
    Pan, An
    Liu, Gang
    DIABETES OBESITY & METABOLISM, 2023, 25 (11): : 3259 - 3267